- Home
- MNKD vs RPD Comparison
MNKD vs RPD Comparison
Compare MNKD & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | RPD |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.0B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MNKD | RPD |
|---|---|---|
| Price | $6.00 | $16.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 21 |
| Target Price | $10.08 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.1M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | 0.10 | ★ 0.35 |
| Revenue | $313,787,000.00 | ★ $858,667,000.00 |
| Revenue This Year | $21.54 | $2.63 |
| Revenue Next Year | $22.21 | $1.65 |
| P/E Ratio | $61.14 | ★ $47.00 |
| Revenue Growth | ★ 17.43 | 3.08 |
| 52 Week Low | $3.38 | $13.21 |
| 52 Week High | $7.07 | $42.09 |
Technical Indicators
Market Signals| Indicator | MNKD | RPD |
|---|---|---|
| Relative Strength Index (RSI) | 66.29 | 55.98 |
| Support Level | $5.59 | $15.73 |
| Resistance Level | $5.90 | $16.88 |
| Average True Range (ATR) | 0.19 | 0.55 |
| MACD | 0.06 | 0.28 |
| Stochastic Oscillator | 99.47 | 82.92 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.